YOLFTbeta
Zhonghong Pulin Medical Products Co. Ltd.

Zhonghong Pulin Medical Products Co. Ltd.

300981 · SHE · Healthcare / Medical Instruments & Supplies

14.80CNY-0.79 (-5.07%)

Price History

Full chart

Market Stats

Previous Close15.59
Open15.48
Day Range14.71 – 15.64
52-Week Range9.21 – 21.46
Volume11.17M
Market Cap8.71B
P/E (TTM)203.00
Forward P/E0.00
EPS0.10
Dividend Yield1.72%
Beta0.39
50-Day Avg15.35
200-Day Avg13.56

About

Zhonghong Pulin Medical Products Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of disposable health protection products, sterile medical devices, and life support solutions in China and internationally. It operates through the Health Protection Products Division; Safe Infusion Products Division; and Innovation and Incubation Product Division segments. The Health Protection Products Division is involved in the research, development, production, and sale of nitrile gloves, PVC gloves, natural latex gloves, radiation protection gloves, polyisoprene gloves, and other gloves and condoms. The Safe Infusion Products Division engages in the research, development, production, and sale of infusion device-related products, such as precision infusion sets, indwelling needles, ordinary infusion sets, ordinary syringes, and blood collection tubes. The Innovation and Incubation Product Division is involved in the research, development, production, and sale of products and equipment, including infusion pumps, syringe pumps, infusion information acquisition systems, disposable non-invasive EEG electrodes, disposable medical temperature sensors, non-invasive blood pressure cuffs, and radial artery compression tourniquets. The company also provides wireless continuous monitoring sensors and probes; and scientific research and technical services. Zhonghong Pulin Medical Products Co., Ltd. was founded in 2010 and is based in Tangshan, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMs. Hao Yang
  • Employees3.88K
  • HeadquartersChengxi Park, Tangshan, China, 063500, China
  • Websitehttps://www.zhonghongmedical.com

Leadership

  • Ms. Hao YangGeneral Manager · b. 1988
  • Mr. Wen Long WangDeputy GM & Financial Director · b. 1988
  • Mr. Mingang LiDeputy General Manager · b. 1971
  • Yuzhu ZhangAccounting Supervisor
  • Mr. Wei DengBoard Secretary · b. 1989

Financials

Income Statement

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue550.61M585.05M604.08M710.08M951.15M967.53M1.17B4.78B4.91B1.57B2.11B2.46B2.37B
Growth (%)-+6.25%+3.25%+17.55%+33.95%+1.72%+21.01%+308.13%+2.74%-67.97%+33.87%+16.69%-3.40%
Cost of Revenue483.02M484.10M469.22M586.08M770.72M801.69M951.55M1.40B2.03B1.55B2.01B2.18B2.11B
Gross Profit67.59M100.94M134.86M124.00M180.43M165.85M219.26M3.38B2.88B18.85M98.31M273.83M264.58M
Gross Margin12.28%17.25%22.33%17.46%18.97%17.14%18.73%70.74%58.73%1.20%4.67%11.15%11.15%
Operating Expense66.86M67.78M83.59M75.69M94.10M95.47M113.09M186.83M95.19M29.85M235.19M339.57M317.87M
Operating Income727.68K33.17M51.27M48.31M86.33M70.38M106.17M3.19B2.79B-11.00M-136.87M-65.74M-53.29M
Operating Margin0.13%5.67%8.49%6.80%9.08%7.27%9.07%66.83%56.79%-0.70%-6.50%-2.68%-2.25%
EBITDA43.70M69.98M86.63M93.34M129.86M120.92M172.88M3.27B2.86B196.91M77.53M171.01M130.14M
EBITDA Margin7.94%11.96%14.34%13.15%13.65%12.50%14.77%68.48%58.35%12.52%3.68%6.96%5.48%
Net Income3.04M24.92M42.31M38.21M65.01M56.67M89.27M2.66B2.34B66.92M-130.87M-87.13M-112.38M
Net Income Margin0.55%4.26%7.00%5.38%6.83%5.86%7.62%55.74%47.70%4.26%-6.22%-3.55%-4.74%
R&D--1.09M1.36M1.92M9.23M9.31M11.65M21.79M8.83M31.61M49.70M51.08M
R&D as % of Total Revenue--0.18%0.19%0.20%0.95%0.80%0.24%0.44%0.56%1.50%2.02%2.15%
Interest Expense15.47M14.83M11.04M11.41M10.56M14.37M20.15M10.28M3.17M3.14M16.68M25.86M31.03M
Interest Expense % of Total Revenue2.81%2.53%1.83%1.61%1.11%1.48%1.72%0.22%0.06%0.20%0.79%1.05%1.31%

Balance Sheet

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets494.91M488.86M575.60M628.88M697.69M974.94M1.08B3.67B7.15B6.82B7.06B7.23B7.44B
Total Liabilities369.38M337.54M384.11M373.63M377.80M598.84M608.28M1.12B597.56M684.05M1.14B1.61B2.02B
Total Equity124.60M150.17M192.96M256.73M321.19M378.24M467.67M2.56B6.55B6.12B5.77B5.47B5.26B
Cash27.89M92.44M53.83M66.44M66.10M31.74M70.98M1.17B844.39M484.76M776.20M597.59M1.21B
Total Debt271.14M223.12M218.45M174.25M169.97M302.47M329.56M107.39M17.18M67.13M492.13M730.31M-
Net Debt243.25M130.67M164.62M107.82M103.87M270.73M258.59M-1.07B-827.20M-417.63M-113.66M132.73M-

Cash Flow

Currency: CNY2013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow13.37M133.33M92.23M102.37M96.03M23.77M184.38M2.72B2.36B106.71M140.68M183.91M3.74M
Investing Cash Flow-9.50M-17.04M-120.91M-61.69M-77.87M-198.76M-147.07M-802.14M-4.12B-75.21M205.52M-513.88M-
Financing Cash Flow-22.69M-63.55M-18.57M-33.07M-14.80M144.97M-22.25M-810.43M1.53B-429.61M39.99M138.98M-
Capital Expenditure10.15M17.04M120.92M61.69M78.09M203.05M150.48M429.43M960.56M207.65M103.17M107.40M190.63M
Free Cash Flow3.22M116.29M-28.69M40.68M17.94M-179.29M33.90M2.29B1.40B-100.95M-61.36M76.51M-186.89M
Dividends Paid15.47M14.93M11.11M61.43M8.56M14.01M19.77M575.00M250.00M500.01M294.64M215.94M126.51M
FCF to OCF24.07%87.22%-31.11%39.74%18.68%-754.38%18.39%84.21%59.34%-94.60%-43.61%41.60%-5002.93%
Dividend Paid to FCF480.98%12.84%-38.73%151.00%47.72%-7.81%58.33%25.11%17.83%-495.33%-480.22%282.24%-67.69%

Earnings

Report DateJun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Mar 14, 2024May 16, 2024Jun 30, 2024Oct 28, 2024Dec 31, 2024Apr 23, 2025Jun 30, 2025Oct 29, 2025Dec 31, 2025Apr 23, 2026Jun 30, 2026
EPS Estimate---------------------
EPS Actual1.600.550.040.140.03-0.080.07-0.010.000.03-0.360.000.070.05-0.320.05-0.03-0.03-0.250.010.36
Surprise---------------------
Timing----------After-hoursAfter-hours-Pre-market-Pre-market-Pre-market-Pre-market-

Key Statistics & Ratios

Market Cap8.71B
Enterprise Value5.99B
Trailing P/E203.00
Forward P/E0.00
Price / Sales3.33
Price / Book1.50
EPS0.10
Book Value12.30
Revenue (TTM)2.61B
Gross Profit (TTM)434.66M
EBITDA314.98M
Profit Margin1.55%
Operating Margin20.07%
Return on Equity0.69%
Return on Assets0.88%
Shares Outstanding428.86M
Shares Float117.02M
Beta0.39
Dividend Yield1.72%
Dividend Rate0.35
Payout Ratio3.69%

Dividends

20261×
0.35May 27, 2026
20251×
0.25Jun 27, 2025
20241×
0.45Jun 27, 2024
20231×
0.64May 26, 2023
20221×
2.10May 30, 2022
20211×
0.58Sep 30, 2021

Stock Splits

  • Jun 27, 20251.1:1
  • May 26, 20231.3:1
  • May 30, 20221.8:1